2007˜The œPsychiatric timesRequires access

The Changing Face of Alcoholism Treatment

Markus Heilig

Open publisher page 0 citations

Abstract

At the core of alcoholism is the pathologically increased motivation to consume alcohol at the expense of natural rewards with disregard for adverse consequences. naltrexone and acamprosate represent the first generation of modern pharmacotherapies that target this pathology.

About this research paper

What this paper is about

At the core of alcoholism is the pathologically increased motivation to consume alcohol at the expense of natural rewards with disregard for adverse consequences. naltrexone and acamprosate represent the first generation of modern pharmacotherapies that target this pathology.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

At the core of alcoholism is the pathologically increased motivation to consume alcohol at the expense of natural rewards with disregard for adverse consequences. naltrexone and acamprosate represent the first generation of modern pharmacotherapies that target this pathology.

Key concepts: Naltrexone, Acamprosate, Addiction, Psychiatry, Adverse effect, Psychology, Medicine, Psychopharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
The Changing Face of Alcoholism Treatment — Research Paper | ScholarLens